CNS Hemangiopericytoma
Authors:
- 1 June 2017
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 40 (3) , 223-227
Abstract
Background: Central nervous system (CNS) hemangiopericytomas are rare mesenchymal tumors of the brain. In the absence of randomized clinical trials or large studies, the only information we have about the natural history and the management is from isolated clinical case series. They have suggested that surgery is beneficial, with conflicting results on the role of complete resection and adjuvant radiation. We have conducted a systematic review of clinical case series of CNS hemangiopericytoma analyzing the biology of the tumor and the best follow-up and management strategy. Methods: Fifteen pertinent clinical case series on newly diagnosed CNS hemangiopericytoma were selected by a review of literature. A total of 523 patients were analyzed for age, sex, mode of recurrence and metastases, and survival after complete/incomplete resection with or without radiation. Results: The mean age was found to be 44.17 (±3.59) years. The incidence was higher in male individuals younger than 45 years and in older female individuals. Complete resection and adjuvant radiation significantly improved survival in comparison with incomplete resection and no radiation, respectively (PP<0.0001). The mean time for distant metastases was seen to be 91.33 (±12.66) months. Conclusions: Complete resection followed by adjuvant radiation improves survival. Extraneural metastases, especially to lung, bone, and liver, are not uncommon and can occur late in the disease course for which continued follow-up is required. There is also a need to establish a systemic treatment regimen to control the distant metastases.Keywords
This publication has 24 references indexed in Scilit:
- Intracranial hemangiopericytomaCancer, 2011
- Hemangiopericytoma: long-term outcome revisitedJournal of Neurosurgery, 2011
- Predictors of mortality following treatment of intracranial hemangiopericytomaJournal of Neurosurgery, 2010
- Inhibiting the VEGF–VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumorCurrent Opinion in Oncology, 2010
- Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case ReportCase Reports in Oncology, 2010
- Management of intracranial meningeal hemangiopericytomas: outcome and experienceNeurosurgical Review, 2006
- Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patientsJournal of Neurosurgery, 2003
- Meningeal hemangiopericytomasSurgical Neurology, 2003
- Hemangiopericytoma—The role of radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Intracranial hemangiopericytoma: Radiology, surgery, radiotherapy, and outcome in 21 patientsSurgical Neurology, 1985